Is Homocysteine Associated with the Prognosis of Covid-19 Pneumonia

Table 1

Evaluation of demographic characteristics, concomitant symptoms, and clinical findings of patients admitted to the COVID-19 ward and intensive care unit.

	COVID-19 ward (n : 134)	Intensive care unit (n : 28)
Gender (n : %)
Male	82 (61.2)	19 (67.9)	x^2: 0.438;
Female	52 (38.8)	9 (32.1)
Age (years) (x ± SD)	60.8 ± 13.91	62.1 ± 13.65	0.643
Length of hospital stay (day) (x ± SD)	14.5 ± 9.89	25.0 ± 24.14	0.0001
Accompanying Symptoms and Clinical Findings (n : %)
Fever	41 (30.6)	5 (17.9)	x^2: 1.849;
Cough	65 (48.5)	9 (32.1)	x^2: 2.500;
Dyspnea	77 (57.5)	18 (64.3)	x^2: 0.445;
Loss of taste and smell	4 (3.0)	—	x^2: 0.857;
Diarrhea	6 (4.5)	—	x^2: 1.302;
Sputum	9 (6.7)	4 (14.3)	x^2: 1.798;
Nausea/vomiting	28 (20.9)	—	x^2: 7.073;
Chest pain	6 (4.5)	2 (7.1)	x^2: 0.350;
Back pain	5 (3.7)	1 (3.6)	x^2: 0.002;
Muscle joint pain	17 (12.7)	1 (3.6)	x^2: 1.948
SpO2 (%) (x ± SD)	92.0 ± 6.38	89.6 ± 6.27	0.073
Temperature (°C) (x ± SD)	37.0 ± 0.77	36.9 ± 0.53	0.637

SpO₂: oxygen saturation.